Efficacy (LDL lowering). In premarketing studies, pitavastatin was shown to reduce low-density lipoprotein cholesterol (LDL) anywhere from 31-45% (pitavastatin 1-4 mg), with pitavastatin 2 mg being non-inferior to atorvastatin 10 mg and simvastatin 20 mg.